Cancer incidence is rising sharply across Asia-Pacific and Africa, and the need for affordable, WHO-approved oncology medicines has never been more urgent in the Philippines, South Africa, Australia, and Singapore. Unnati Pharmax supplies a comprehensive range of generic cancer medicines to all four markets, helping patients, hospitals, and NGOs access life-saving treatments at a fraction of branded prices.
In Manila, Cebu, and Davao in the Philippines, blood cancers including leukaemia, lymphoma, and ITP are significant causes of morbidity. The Philippine General Hospital and provincial cancer centres face chronic shortages of affordable Imatinib (generic Gleevec) for CML patients and Eltrombopag (generic Promacta/Revolade) for ITP and aplastic anaemia patients. Indian generics from Unnati Pharmax directly address these supply gaps at accessible prices for Filipino patients and hospitals.
In South Africa, prostate cancer is the most commonly diagnosed cancer in men, with rising incidence in Johannesburg, Cape Town, Durban, and Pretoria. Generic Abiraterone Acetate 250mg (Abiranamo, generic Zytiga) from India offers South African prostate cancer patients access to this life-extending treatment at a cost that is genuinely manageable — unlike the South African private market price of brand Zytiga which exceeds ZAR 30,000 per month.
In Australia and Singapore, private oncology patients and medical tourists increasingly source WHO-GMP certified Indian generics for multiple myeloma (Lenalidomide, Bortezomib), blood disorders (Eltrombopag), and haematological cancers (Imatinib) to reduce out-of-pocket costs significantly. Both the TGA in Australia and HSA in Singapore recognise WHO-GMP certified Indian generics as acceptable quality standards for personal import.
Unnati Pharmax ships all oncology products to the Philippines, South Africa, Australia, and Singapore via DHL and FedEx with full country-specific documentation. Visit medshopy.com or WhatsApp +91 82650 41513 for international pricing and delivery details.
